Filter:
August 18, 2020 The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) has announced the award […]
Nazli Khodayari, PhD receives the 2020 John W. Walsh Translational Research Award for the research grant entitled “Novel Biomarkers for […]
Read More… from 2020 John W. Walsh Translational Research Award
Dear Secretary Azar: On behalf of the Plasma Protein Therapeutics Association (PPTA), we wish to commend the Department’s efforts to […]
What better way for the Alpha-1 community to thank plasma donors and staff than from the heart! Let them know […]
August 4, 2020– President Trump signed an Executive Order on Improving Rural Health and Telehealth Access. The purpose of the […]
Want to learn how to make your voice heard to change public policy while raising awareness for Alpha-1 Antitrypsin Deficiency? […]
Read More… from Advocacy Webinar Summer Series: Register today, to help change tomorrow for Alphas!
The Alpha-1 Foundation is proud to announce and introduce its newest Board of Director, Jon Hagstrom. Jon Hagstom was diagnosed […]
Read More… from Alpha-1 Foundation welcomes new Board of Director, Jon Hagstrom
Register now for a great Alpha-1 fundraiser, Saturday, August 1, 2020 at 9:00 AM ET Clarissa (Chris) Riely started practicing […]
Read More… from Join Alpha, Chris Riely for a summer virtual Building Friends for a Cure Yoga Class
On July 17th, the COPD Community lost one of its best friends, Congressman John Lewis. We have all been aware […]
Re: Proposed Research Approach for Chronic Obstructive Pulmonary Disease: Screening Dear Task Force Members: The Alpha-1 Foundation appreciates the opportunity […]
Read More… from Proposed Research Approach for Chronic Obstructive Pulmonary Disease: Screening
In the light of the unfolding COVID-19 pandemic, there is urgent need for new therapies, particularly for critically ill patients. […]
Read More… from ISCT Statement on the Marketing of Unproven Stem Cell Treatments for COVID-19
Individuals with the genetic disorder alpha-1 antitrypsin deficiency (AATD) are at risk of developing lung and liver disease. Patient induced […]
The Alpha-1 Foundation congratulates Dr. James Crapo on his new appointment as the Chairman of the Board of Directors and […]
From the Desk of Miriam O’Day:Day three of the conference kicked off with an incredible presentation from keynote speaker, Dr. […]
Read More… from Virtual Alpha-1 National Conference: Day 3 Recap
Day 2 Recap “I have enjoyed all of the sessions and presentations. Such excellent questions from the community!” […]
Read More… from Virtual Alpha-1 National Conference: Day 2 Recap
“All of our experts have been so generous with their genius.” – Richard Lovrich, Alpha-1 patient. Thank you for registering […]
Read More… from Virtual Alpha-1 National Conference: Day 1 Recap
The Alpha-1 Foundation is excited to launch the first ever Virtual National Conference. In 2020, we have provided the entire […]
Read More… from Be Part of the First Ever Virtual Alpha-1 National Conference…. Here’s Why
Study on liver involvement in mild alpha-1-antitrypsin deficiency published in “Gastroenterology” The Alpha1-Liver Team from Aachen, Germany, which coordinates the […]
The 26 undersigned organizations are pleased to submit our comments on the Centers for Medicare & Medicaid Services’ (CMS’) continuing […]
Diana Berrent learned she had tested positive for COVID-19 on a Wednesday in mid-March. Within a day, she had received […]
Read More… from COVID Survivors’ Blood Plasma Is A Sought-After New Commodity
Co-authored by Alpha-1 Foundation Board of Director James Stoller, MD, MS CLEVELAND — Tips to avoid becoming infected with COVID-19 […]
25 April 2020 marked the third annual European Alpha-1 Awareness Day, a date in which those afflicted with the genetic […]
Joanne Mellady, an incredible individual and active volunteer of the Alpha-1 Foundation is remembered for her love of life. Joanne […]
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against […]
